Avai Bio, Inc.
AVAI· OTC
AVAIAvai Bio, Inc.
Filed Aug 19, 2024 · 10-Q · 50 days after period end · 0001740797-24-000042
| Metric | Q1 2025 | Q1 2024 | Q1 2021 | Q1 2020 |
|---|---|---|---|---|
| Net Income | -$528.84K | -$411.52K | $396.33K | $48.68K |
| EPS Diluted | — | — | — | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Avai Bio, Inc. · CIK 1740797 · Engraved from SEC EDGAR
ended Jun 30, 2024 · filed Aug 19, 2024 · 50 d after period end
